10-26560836-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019043.4(APBB1IP):c.1361C>T(p.Pro454Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,592,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019043.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APBB1IP | NM_019043.4 | c.1361C>T | p.Pro454Leu | missense_variant | 13/15 | ENST00000376236.9 | NP_061916.3 | |
APBB1IP | XM_011519514.3 | c.1217C>T | p.Pro406Leu | missense_variant | 12/14 | XP_011517816.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APBB1IP | ENST00000376236.9 | c.1361C>T | p.Pro454Leu | missense_variant | 13/15 | 5 | NM_019043.4 | ENSP00000365411 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151852Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000726 AC: 17AN: 234206Hom.: 0 AF XY: 0.0000626 AC XY: 8AN XY: 127728
GnomAD4 exome AF: 0.0000139 AC: 20AN: 1440372Hom.: 0 Cov.: 30 AF XY: 0.0000125 AC XY: 9AN XY: 717550
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151852Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74158
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | The c.1361C>T (p.P454L) alteration is located in exon 13 (coding exon 11) of the APBB1IP gene. This alteration results from a C to T substitution at nucleotide position 1361, causing the proline (P) at amino acid position 454 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at